Response Biomedical Corp ($RBM) - buy or sell? Stock discussion, ideas, forum

Response Biomedical Corp

Response Biomedical Corporation is a health care company.

Industry: Consumer, Non-cyclical

Ticker	Exchange	ISIN
$RBM	TSX	CA76123L3039

Recent news

Kinaxis Inc Net Income dropped on 41.2% while Revenue surged on 17.0%

B2Gold Corp reports 114% Net Income growth in 2020 and 11.0 pp EBITDA Margin growth from 65.6% to 76.6%

Tucows Inc reports 35.8% EBITDA decline in 2020 and 7.7% Revenue decline

KFG Resources Ltd reports 23.7% revenue decline in FY2020 and 25.1 pp EBITDA Margin decline from -3.5% to -28.6%

EXFO Inc EBITDA dropped on 30.3% and Revenue decreased on 7.4%

Arctic Hunter Energy Inc revenue decline accelerated to 47.8% in FY2020 vs. 37.7% a year earliner

Canyon Creek Food Co Ltd reports 38.5% revenue growth in FY2020 and 0.53 pp EBITDA Margin decline from -13.1% to -13.7%

Orbit Garant Drilling Inc Debt surged on 39.8% and Net Debt / EBITDA surged on 1.1x from 3.0x to 4.1x

Rochester Resources Ltd revenue returned to growth in FY2020: increased 13.2% vs. 19.2% decline a year earliner

Quizam Media Corp reports 8.0% revenue decline in FY2020 and 80.7 pp EBITDA Margin growth from -265% to -184%

Twit about RBM stock

Share your investment idea or question on Response Biomedical Corp stock:

Latest twits on Response Biomedical Corp (RBM)

No twits yet. Be the first to post!

Have a question about RBM? Ask and other investors will be eager to help you.

Have an idea about RBM? Share it with other investors.

Response Biomedical Corp news

21.03.2016 Response Biomedical Corp EBITDA Margin surged on 45.0 pp from -36.7% to 8.4% in 2015 and Revenue surged on 40.0%

Response Biomedical Corp stock price chart

Response Biomedical Corp financials

mln. CAD	FY2010	FY2011	FY2012

Revenue	7.113	9.473	11.750
EBITDA	-7.984	-3.720	-3.059
Net income	-10.082	-5.371	-5.281
CAPEX	0.092	0.106	0.311
Debt	0.000	0.000	0.000
Cash	4.330	7.355	2.080

Response Biomedical Corp news

21.03.2016 Response Biomedical Corp EBITDA Margin surged on 45.0 pp from -36.7% to 8.4% in 2015 and Revenue surged on 40.0%

About Response Biomedical Corp

Response Biomedical Corporation is a health care company. The Company researches and commercializes diagnostic tests for the human health, food safety and environmental markets. Response Biomedical markets its product under the RAMP brand name.